Pituitary adenylate cyclase-activating polypeptide (PACAP) in fetal cord blood

Early Human Development

Volumn 90, Issue 9, 2014, Pages 451-453

  Winters, Stephen J ^a   King, Jeffrey C ^a   Brees, Carol K ^a   Moore, Joseph P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cord blood; PACAP; Stress

Indexed keywords

APROTININ; EDETIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; FEMALE; FETUS; FETUS GROWTH; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LABOR; MALE; PLACENTA; UMBILICAL CORD BLOOD; VAGINAL DELIVERY; VENOUS BLOOD; BLOOD; FETUS BLOOD; METABOLISM; NEWBORN; RADIOIMMUNOASSAY;

FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RADIOIMMUNOASSAY;

EID: 84905275950     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2014.06.001     Document Type: Article

References (20)

1. Barker D.J. Sir Richard Doll Lecture. Developmental origins of chronic disease. Public Health 2012, 126:185-189.
2. Austin M.P., Leader L.R., Reilly N. Prenatal stress, the hypothalamic-pituitary-adrenal axis, and fetal and infant neurobehaviour. Early Hum Dev 2005, 81:917-926.
3. Miyata A., Arimura A., Dahl R.R., et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989, 164:567-574.
4. Vaudry D., Falluel-Morel A., Bourgault S., et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20years after the discovery. Pharmacol Rev 2009, 61:283-357.
5. Stroth N., Holighaus Y., Ait-Ali D., Eiden L.E. PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Ann N Y Acad Sci 2011, 1220:49-59.
6. Hannibal J., Jessop D.S., Fahrenkrug J., et al. PACAP gene expression in neurons of the rat hypothalamo-pituitary-adrenocortical axis is induced by endotoxin and interleukin-1beta. Neuroendocrinology 1999, 70:73-82.
7. Hammack S.E., Cheung J., Rhodes K.M., et al. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 2009, 34:833-843.
8. Kageyama K., Hanada K., Iwasaki Y., et al. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J Endocrinol 2007, 195:199-211.
9. Koch B., Lutz-Bucher B. Vasopressin, unlike phorbol ester, fails to synergistically interact with pituitary adenylate cyclase activating polypeptide (PACAP) in stimulating cyclic AMP formation and ACTH secretion in cultured anterior pituitary cells. Mol Cell Endocrinol 1993, 92:175-181.
10. Stroth N., Liu Y., Aguilera G., Eiden L.E. Pituitary adenylate cyclase-activating polypeptide controls stimulus-transcription coupling in the hypothalamic-pituitary-adrenal axis to mediate sustained hormone secretion during stress. J Neuroendocrinol 2011, 23:944-955.
11. Stroth N., Eiden L.E. Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling. Neuroscience 2010, 165:1025-1030.
12. Smith C.B., Eiden L.E. Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse?. J Mol Neurosci: MN 2012, 48:403-412.
13. Ressler K.J., Mercer K.B., Bradley B., et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011, 470:492-497.
14. Chang S.C., Xie P., Anton R.F., et al. No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. Mol Psychiatry 2012, 17:239-241.
15. Moore J.P., Villafuerte B.C., Unick C.A., Winters S.J. Developmental changes in pituitary PACAP expression during the perinatal period: possible role in fetal gonadotroph regulation. Endocrinology 2009, 150:4802-4809.
16. Reglodi D., Gyarmati J., Ertl T., et al. Alterations of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth. J Endocrinol Invest 2010, 33:443-445.
17. Koh P.O., Kwak S.D., Kim H.J., et al. Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta. Mol Reprod Dev 2003, 64:27-31.
18. Brubel R., Boronkai A., Reglodi D., et al. Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cells. J Mol Neurosci: MN 2010, 42:450-458.
19. Steenstrup B.R., Jorgensen J.C., Alm P., et al. Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit. Regul Pept 1996, 61:197-204.
20. Sherwood N.M., Adams B.A., Isaac E.R., et al. Knocked down and out: PACAP in development, reproduction and feeding. Peptides 2007, 28:1680-1687.